SPDR S&P Pharmaceuticals ETF (XPH) Chart & Stock Price History $45.12 +0.07 (+0.16%) As of 01:09 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Stock Price Performance 5 Day Performance+3.18%1 Month Performance+3.94%3 Month Performance-1.74%6 Month Performance+6.57%Year-To-Date Performance+4.95%1 Year Performance+7.71% Receive XPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address XPH Stock Chart for Friday, January, 24, 2025 XPH Chart by TradingView SPDR S&P Pharmaceuticals ETF Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/23/2025$44.50$45.05+1.24%$45.05$44.2651,466 shs$218.49 million01/22/2025$44.70$44.50-0.45%$44.62$44.2716,443 shs$215.83 million01/21/2025$43.73$44.70+2.22%$44.70$44.0454,212 shs$216.80 million01/20/2025$43.73$43.73$44.19$43.7224,915 shs$212.09 million01/17/2025$43.98$43.73-0.57%$44.19$43.7224,915 shs$212.09 million01/16/2025$43.85$43.98+0.30%$44.09$43.3835,950 shs$213.30 million01/15/2025$43.06$43.85+1.83%$43.90$43.4416,174 shs$212.67 million01/14/2025$43.49$43.06-0.99%$43.69$42.7548,042 shs$208.84 million01/13/2025$42.72$43.49+1.80%$43.49$42.6325,902 shs$210.93 million01/10/2025$42.82$42.72-0.23%$42.79$42.3839,189 shs$207.19 million Get the Latest News and Ratings for XPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 01/09/2025$42.82$42.82$42.88$42.2234,913 shs$207.68 million01/08/2025$42.85$42.82-0.07%$42.88$42.2234,913 shs$207.68 million01/07/2025$42.60$42.85+0.59%$43.11$42.7114,831 shs$207.82 million01/06/2025$43.02$42.60-0.98%$43.07$42.6019,228 shs$206.61 million01/03/2025$42.64$43.02+0.89%$43.06$42.7615,751 shs$208.65 million01/02/2025$42.99$42.64-0.81%$43.22$42.5132,164 shs$206.80 million01/01/2025$42.99$42.99$43.11$42.6890,421 shs$208.50 million12/31/2024$42.71$42.99+0.66%$43.11$42.6890,421 shs$208.50 million12/30/2024$43.49$42.71-1.79%$43.11$42.4561,953 shs$207.14 million12/27/2024$44.04$43.49-1.25%$44.02$43.3513,292 shs$210.93 million12/26/2024$43.41$44.04+1.45%$44.05$43.3115,181 shs$213.59 million12/25/2024$43.41$43.41$43.47$43.0886,594 shs$210.54 million12/24/2024$43.41$43.41$43.47$43.0886,594 shs$210.54 million12/23/2024$43.42$43.41-0.02%$43.49$42.9632,662 shs$210.54 million Related Companies Direxion Daily Healthcare Bull 3x Shares Stock Chart Invesco S&P SmallCap Health Care ETF Stock Chart Simplify Health Care ETF Stock Chart Invesco Dorsey Wright Healthcare Momentum ETF Stock Chart SPDR S&P Health Care Equipment ETF Stock Chart ALPS Medical Breakthroughs ETF Stock Chart Invesco Biotechnology & Genome ETF Stock Chart ProShares Ultra Health Care Stock Chart SPDR S&P Health Care Services ETF Stock Chart Simplify Propel Opportunities ETF Stock Chart Receive XPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:XPH) was last updated on 1/24/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredLegendary Investor: “Buy These “Trump Stocks Now”Within the first week of Trump's election, several stocks exploded for double- and triple-digit gains. Acco...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
